As such, they are more closely associated with biomarkers of Aβ pathology and, accordingly to the new Alzheimer’ Association criteria [59], are classified as phosphorylated and secreted AD tau (T1) biomarkers. The gene discussed is MAPT; the disease is Alzheimer disease.